VMP 14608411000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Tolterodine 4mg modified-release capsules
BNF code 0704020N0AAACAC
Virtual Therapeutic Moiety Tolterodine
Date identifier became valid 30 Oct 2008
Previous product identifier 400728002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Tolterodine tartrate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 4.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsulemodified-release.oral
Dose Form
Formulation Modified-release capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Blerone XL 4mg capsules (Zentiva Pharma UK Ltd)
Detrusitol XL 4mg capsules (CST Pharma Ltd)
Detrusitol XL 4mg capsules (Sigma Pharmaceuticals Plc)
Detrusitol XL 4mg capsules (Viatris UK Healthcare Ltd)
Mariosea XL 4mg capsules (Teva UK Ltd)
Neditol XL 4mg capsules (Aspire Pharma Ltd)
Preblacon XL 4mg capsules (Accord-UK Ltd)
Tolterma XL 4mg capsules (Macleods Pharma UK Ltd)
Tolthen XL 4mg capsules (Northumbria Pharma Ltd)
Virtual Medicinal Product Packs
Tolterodine 4mg modified-release capsules 28 capsule
Tolterodine 4mg modified-release capsules 30 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback